Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Begoña Pineda, Ángel Díaz‐Lagares, José Alejandro Pérez Fidalgo, Octavio Burgués, Inés González‐Barrallo, Ana B. Crujeiras, Juan Sandoval, Manel Esteller, Aña Lluch, Pîlar Eroles (2019). A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients. , 11(1), DOI: https://doi.org/10.1186/s13148-019-0626-0.
Article188 days agoA phase II clinical trial to analyze olaparib response in patients with <i>BRCA1</i> and/or <i>BRCA</i>2 promoter methylation with advanced breast cancer (GEICAM/2015-06 COMETA-Breast study).
Juan de la Haba-Rodríguez, Ángel Guerrero‐Zotano, José Alejandro Pérez Fidalgo, Santiago González Santiago, Montserrat Muñoz, Raquel Andrés, Cristina Cruz Zambrano, Sebastian Moran Salama, Sara López‐Tarruella, Vanesa Garcı́a, Sònia Servitja, Mireia Melé, Sonia Alonso Soler, Bárbara Adamo, M.J. Escudero, N Martin, Susana Bezares, Rosalía Caballero, Manel Esteller, Federico Rojo (2018). A phase II clinical trial to analyze olaparib response in patients with <i>BRCA1</i> and/or <i>BRCA</i>2 promoter methylation with advanced breast cancer (GEICAM/2015-06 COMETA-Breast study).. , 36(15_suppl), DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.tps1114.
Article188 days agoDNA methylation signature to identify treatment response in triple negative breast cancer.
Begoña Pineda, Ángel Díaz‐Lagares, José Alejandro Pérez Fidalgo, Elisa Alonso, Juan Sandoval, Ines González, Ana-Belen Crujeiras, Octavio Burgués, Manel Esteller, Aña Lluch, Pîlar Eroles (2015). DNA methylation signature to identify treatment response in triple negative breast cancer.. , 33(15_suppl), DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.1079.
Article188 days agoDNA methylation as an epigenetic signature predictive of response to neodjuvant treatment in TNBC patients.
Begoña Pineda, José Alejandro Pérez Fidalgo, Ángel Díaz‐Lagares, Octavio Burgués, Inés González‐Barrallo, Ana B. Crujeiras, Juan Sandoval, Manel Esteller, Pîlar Eroles, Aña Lluch (2018). DNA methylation as an epigenetic signature predictive of response to neodjuvant treatment in TNBC patients.. , 36(15_suppl), DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e12658.
Article188 days ago